Portfolio company
Claryx
United States · £2.8m raised
Raised
£2.8m
Latest stage
Pre-seed
Rounds recorded
1
Backed by
6 investors
Sectors
About
Claryx develops a genomic surveillance platform that sequences pathogen DNA to detect and trace infection outbreaks for hospitals and healthcare systems.
SourceFunding history · 1
Similar companies
NEX Health Intelligence
NEX Health Intelligence develops an artificial intelligence platform for hospitals to detect, predict and prevent healthcare-associated infections.
Biotia
This company develops genomic sequencing software and diagnostic tests to identify infectious diseases for hospitals, researchers and patients.
Informuta
Informuta develops a predictive software platform using genomic sequencing and artificial intelligence to forecast antibiotic resistance in bacteria for healthcare providers.
Karius
Karius develops genomic blood tests that identify pathogens to help clinicians diagnose infectious diseases in patients.
Delve Bio
This company provides metagenomic next-generation sequencing tests and diagnostic software to clinicians and laboratories for identifying pathogens in infectious diseases.
IDbyDNA
This company develops metagenomics software and diagnostic tests to identify pathogens and microorganisms for clinical laboratories, healthcare providers and researchers.
D-Nome
This company develops point-of-care molecular diagnostic kits and genomic sequencing tools for healthcare providers, laboratories, and agricultural clients to detect infectious diseases.
Clear Labs
This company develops automated next-generation sequencing platforms for food safety testing and infectious disease surveillance for food producers and public health agencies.
